Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imaging diagnosis.

Riccardo Lencioni1, Dania Cioni, Clotilde Della Pina

  • 1Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, I-56125 Pisa, Italy. Lencioni@do.med.unipi.it

Seminars in Liver Disease
|May 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI-Based Radiomics to Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Retrospective Study.

Journal of personalized medicine·2026
Same author

Radiogenomics in Lymphoma and Multiple Myeloma: A Systematic Review of Current Evidence and Future Directions.

Journal of clinical medicine·2026
Same author

Cardiac magnetic resonance in patients with acute myocardial infarction: The added clinical value.

Vascular pharmacology·2026
Same author

Outcomes of Y90-radioembolization as downstaging to liver transplantation in patients with hepatocellular carcinoma and tumoral portal vein thrombosis.

Hepatology (Baltimore, Md.)·2026
Same author

Radiomics analysis of restaging MRI for detection of pathological complete response in locally advanced rectal cancer.

European journal of radiology open·2026
Same author

Characterization of Patients with Unresectable Hepatocellular Carcinoma in REFLECT Who Achieved Tumor Response or Alpha-Fetoprotein Response When Treated with Lenvatinib.

Liver cancer·2026
Same journal

Hepatosystemic T cell licensing in MASLD-associated neuroinflammation.

Seminars in liver disease·2026
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
See all related articles

Diagnosing hepatocellular carcinoma (HCC) in cirrhotic patients is challenging due to similar imaging findings in nonmalignant lesions. Advanced imaging like CT and MRI are crucial for confirming HCC, especially in larger nodules with characteristic vascularity.

Area of Science:

  • Hepatology
  • Radiology
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) diagnosis relies on imaging, clinical, and lab findings.
  • Distinguishing small HCC from benign lesions in cirrhotic livers is challenging.
  • Vascular supply patterns are key for differentiating HCC on imaging.

Purpose of the Study:

  • To review the diagnostic challenges and imaging techniques for hepatocellular carcinoma in cirrhotic patients.
  • To highlight the role of vascularity in differentiating HCC from other liver lesions.
  • To discuss the limitations of current imaging modalities in detecting small HCCs.

Main Methods:

  • Review of current literature on HCC diagnosis in cirrhosis.
  • Analysis of imaging characteristics, particularly vascular supply, of HCC and nonmalignant lesions.

Related Experiment Videos

  • Comparison of ultrasonography, CT, and MRI for HCC surveillance and diagnosis.

    • Main Results:

    • Characteristic arterial hypervascularization aids HCC diagnosis in nodules >2 cm.
    • Lesions between 1-2 cm often require biopsy, though negative results don't exclude malignancy.
    • Spiral CT and dynamic MRI are preferred over invasive methods but struggle with tiny lesions and subtle vascular invasion.

    Conclusions:

    • Accurate HCC diagnosis in cirrhosis requires integrating imaging with clinical and laboratory data.
    • Vascular imaging features are critical for differentiating HCC, especially in larger nodules.
    • Further advancements are needed to improve the detection sensitivity of small HCCs and early vascular invasion.